Carcinogenesis, Vol. 23, No. 10, 1609-1616,
October 2002
© 2002 Oxford University Press
CANCER BIOLOGY |
Reporter gene transactivation by human p53 is inhibited in thioredoxin reductase null yeast by a mechanism associated with thioredoxin oxidation and independent of changes in the redox state of glutathione
1 Molecular and Cellular Biology Program, Oregon State University, Corvallis, Oregon 97331,
2 Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331,
3 Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA
Reporter gene transactivation by human p53 is compromised in S. cerevisiae lacking the TRR1 gene encoding thioredoxin reductase. The basis for p53 inhibition was investigated by measuring the redox state of thioredoxin and glutathione in wild-type and 
trr1 yeast. The trr1 mutation affected the redox state of both molecules. About 34% of thioredoxin was in the disulfide form in wild-type yeast and increased to 70% in trr1 yeast. About 18% of glutathione was in the GSSG form in wild-type yeast and increased to 32% in trr1 yeast. The trr1 mutation also resulted in a 2.9-fold increase in total glutathione per mg extract protein. Highcopy expression of the GLR1 gene encoding glutathione reductase in trr1 yeast restored the GSSG:GSH ratio to wild-type levels, but did not restore p53 activity. Also, p53 activity was shown to be unaffected by a glr1 mutation, even though the mutation was known to result in glutathione oxidation. In summary, the results show that, although glutathione becomes more oxidized in trr1 cells, glutathione oxidation is neither sufficient nor necessary for p53 inhibition. The results indicate that p53 activity has a specific requirement for an intact thioredoxin system, rather than a general dependence on the intracellular reducing environment.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. B. Cassidy, K. Edes, C. C. Nelson, K. Parsawar, F.A. Fitzpatrick, and P. J. Moos Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles Carcinogenesis, December 1, 2006; 27(12): 2538 - 2549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Koc, C. K. Mathews, L. J. Wheeler, M. K. Gross, and G. F. Merrill Thioredoxin Is Required for Deoxyribonucleotide Pool Maintenance during S Phase J. Biol. Chem., June 2, 2006; 281(22): 15058 - 15063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Hansen, H. Zhang, and D. P. Jones Mitochondrial Thioredoxin-2 Has a Key Role in Determining Tumor Necrosis Factor-{alpha}-Induced Reactive Oxygen Species Generation, NF-{kappa}B Activation, and Apoptosis Toxicol. Sci., June 1, 2006; 91(2): 643 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Damdimopoulos, A. Miranda-Vizuete, E. Treuter, J.-A. Gustafsson, and G. Spyrou An Alternative Splicing Variant of the Selenoprotein Thioredoxin Reductase Is a Modulator of Estrogen Signaling J. Biol. Chem., September 10, 2004; 279(37): 38721 - 38729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Re Intracellular Renin and the Nature of Intracrine Enzymes Hypertension, August 1, 2003; 42(2): 117 - 122. [Abstract] [Full Text] [PDF]
|
|